Form 4: Biodesix Director Reports Stock Transaction
Insider Transaction (Form 4)
John Patience, a Director of Biodesix Inc, reported multiple transactions in common stock on September 30, 2026.
Summary
- Option exercise/conversion: acquired 1,360 Common Stock on September 30, 2026; holds 26,743 after (Direct).
- Option exercise/conversion: disposed of 1,360 Restricted Stock Units on September 30, 2026; holds 1,361 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John Patience — Director, Other (Chairman)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Option exercise/conversion | Common Stock | 1,360 | — | — | 26,743 |
| 2026-09-30 | Option exercise/conversion | Restricted Stock Units | 1,360 | — | — | 1,361 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Option exercise/conversion (1,360 shares) |
| 2026-09-30 | Option exercise/conversion (1,360 shares) |
Keywords
insider transaction, Form 4, BDSX, BIODESIX INC, neutral, John Patience
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.